Drug

LIFASTUZUMAB VEDOTIN

Drug TypeAction TypeMechanism of ActionApprovedMax Trial PhaseMax GBM Phase
Antibody BINDING AGENT Sodium-dependent phosphate transport protein 2B binding agent no 2 0